Again you haven't understood what I said.
Of course DNA affects the way drugs affect you. So does epigenetics. And the way stem affect you is no different. So saying DNA is important for drugs but not MSCs doesn't make any sense.
And I said there are stage 3 trials ongoing. That's the hurdle. That's the risk. That's where most companies fail.
I don't think I could be any more clear. Thanks
MESO action tonight, page-866
-
- There are more pages in this discussion • 2,294 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.065(4.69%) |
Mkt cap ! $1.655B | |||
| Open | High | Low | Value | Volume |
| $1.39 | $1.50 | $1.38 | $7.016M | 4.856M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10425 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 44243 | 5 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |